Michael J. Eblan, MD

Articles by Michael J. Eblan, MD

Hypofractionation for Breast Cancer: Lessons Learned From Our Neighbors to the North and Across the Pond

ByMichael J. Eblan, MD,Noam A. VanderWalde, MD,Elaine M. Zeman, PhD,Ellen Jones, MD, PhD

June 15th 2014

In this review we discuss the rationale and underlying radiobiologic concepts for hypofractionation, and review the clinical trials and ASTRO guidelines supporting hypofractionated radiation in the treatment of breast cancer.

Latest Updated Articles

$Hypofractionation for Breast Cancer: Lessons Learned From Our Neighbors to the North and Across the Pond$
Hypofractionation for Breast Cancer: Lessons Learned From Our Neighbors to the North and Across the Pond
June 15th 2014

Trending on CancerNetwork

FDA Approves Zenocutuzumab in NRG1+ Cholangiocarcinoma Post Systemic Therapy

FDA Clears AI Stratification Tool in HR+/HER2– Invasive Breast Cancer

Daraxonrasib Shows Anti-Tumor Activity in Pretreated RAS+ Pancreatic Cancer

TIP125 ReDiscover-2, a Phase 3 Study of Zovegalisib (RLY-2608) + Fulvestrant Versus Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-Mutant HR+/ HER2- Breast Cancer Following Recurrence or Progression on or After Treatment With a CDK4/6 Inhibitor (Trial in Progress)